Monica C Di Pietro, Evelyn B Doering-Silveira, Maria Paula T Oliveira, Leonardo Q Rosa-Oliveira, Dartiu Xavier Da Silveira
Factors associated with the use of solvents and cannabis by medical students
Addictive behaviors
recruiting special populations smoking cessation trials challenging approaches beyond inclinic recruitment may beneficial secondary analysis data smoking cessation rct individuals history cervical cancer cervical intraepithelial neoplasia cin explored differences associated inclinic vs online recruitment participants recruited clinics within universitybased ncidesignated cancer center n87 online nationally via facebook n115 baseline measures included sociodemographics smoking history cancer cin history study retention smoking abstinence assessed 12 months postbaseline group differences baseline characteristics evaluated retention abstinence evaluated controlling group differences predictors participants recruited online vs inclinic higher educational attainment p01 health literacy p003 likely cin vs cancer time diagnosis completed active treatment p values001 controlling group differences independent predictors retention higher among participants recruited online loglikelihood 211141 p001 recruitment differences selfreported p90 biochemically confirmed smoking abstinence p18 compared individuals recruited inperson individuals recruited online educated higher health literacy presented different clinical profile ie likely cin vs cancer completed active treatment differences participant characteristics recruitment approaches differences smokingrelated variables online recruitment potential improve enrollment cancer survivors smoking cessation trials people history cin cervical cancer recruited smoking cessation rct online vs inclinic likely diagnosis cin vs cancer educated health literate participants recruited online likely retained study differences smoking abstinence rates 12months incorporating online recruitment increased reach tobacco treatment efforts larger diverse sample could reduce burden tobaccorelated disease improve cin cancer treatment outcomes reduce secondary malignancies morbidity among underserved group